![]()
Juvenile idiopathic arthritis (JIA) patients respond positively to omega-3 fatty acid supplementation. Twenty seven JIA patients (12.78 +/- 3.26 y), disease duration approximately 5.93 y (+/- 3.06 y), age of onset 6.78 y (+/- 3.26 y), were given twice daily supplements of omega-3 fatty acids over a period of 12 weeks. The study measured the effect of supplements on clinical manifestations, laboratory investigations, disease activity, functional capacity, response criteria, interleukin-1 (IL-1) and tumor necrosis factor-a (TNF-a) levels. The overwhelming majority of patients experienced improvement in the American College of Rheumatology response criteria, with significant boost in active joint count, number of swollen joints, JADAS-27, CHAQ, TNF-a, and IL-1 levels. Patients were able to decrease use of nonsteroidal anti-inflammatory drugs (NSAIDS). These results support the adjunctive use of omega-3 fatty acids in concert with conventional therapies in the treatment of pat ients with juvenile idiopathic arthritis.
Click here to visit the journal website. Subscription required to view the full text of the article.